lobbying_activities: 1333031

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1333031	029ad4a8-6527-4f9c-8a12-7abc76fa4ac9	Q4	PARRY, ROMANI, DECONCINI & SYMMS	30792	AMGEN USA INC.	2012	fourth_quarter	MMM	Medicare Part D reimbursement issues dealing with patient payments in the "doughnut hole." No legislation introduced. Monitor PDUFA (Prescription Drug User Fee Act) reauthorization under S. 3187, Food and Drug Administration Safety and Innovation Act.	SENATE	45000		0	0	2013-01-11T14:32:56.727000-05:00